Endoscopic Ultrasound-Guided Transesophageal Pericardiocentesis in the Treatment of Localized Cardiac Tamponade Following Coronary Perforation

Autor: Camilla Lundahl, MD, Per Ejstrud, MD, Martin Kirk Christensen, MD

Publikováno v: JACC: Case Reports, Vol 29, Iss 11, Pp 102346- (2024)

We present a case of an 81-year-old male patient who developed a posteriorly localized pericardial effusion and tamponade of the left atrium after percutaneous intervention of the right coronary artery. Endoscopic ultrasound–guided transesophageal

Externí odkaz: https://doaj.org/article/d75be5abfa854dffa2174a9ca53427d3

Effectiveness and safety of P2Y12 inhibitors in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: a nationwide registry-based study

Autor: Sissel J Godtfredsen, Kristian H Kragholm, Peter Leutscher, Steen Hylgaard Jørgensen, Martin Kirk Christensen, Jawad H Butt, Gunnar Gislason, Lars Køber, Emil L Fosbøl, Maurizio Sessa, Deepak L Bhatt, Christian Torp-Pedersen, Manan Pareek

Publikováno v: Godtfredsen, S J, Kragholm, K H, Leutscher, P, Jørgensen, S H, Christensen, M K, Butt, J H, Gislason, G, Køber, L, Fosbøl, E L, Sessa, M, Bhatt, D L, Torp-Pedersen, C & Pareek, M 2022, ' Effectiveness and safety of P2Y12 inhibitors in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention : a nationwide registry-based study ', European Heart Journal: Acute Cardiovascular Care, vol. 11, no. 9, zuac095, pp. 697-705 . https://doi.org/10.1093/ehjacc/zuac095

Aims To compare the effectiveness and safety of clopidogrel, ticagrelor, and prasugrel in patients with ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI). Methods and results Nationwide, registry-b

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79103f4edb5e6a6dd5bf56a7c48cd1a6
https://doi.org/10.1093/ehjacc/zuac095

Autosomal dominant cutis laxa and critical stenosis of the left main coronary artery in a 21-year-old female with an intronic mutation in the elastin gene

Autor: Nikolaj Thure Krarup, Marie Hvidbjerg, Tomás Zaremba, Mette Sommerlund, Martin Kirk Christensen

Publikováno v: Krarup, N T, Hvidbjerg, M, Zaremba, T, Sommerlund, M & Christensen, M K 2023, ' Autosomal dominant cutis laxa and critical stenosis of the left main coronary artery in a 21-year-old female with an intronic mutation in the elastin gene ', American Journal of Medical Genetics, Part A, vol. 191, no. 4, pp. 1059-1064 . https://doi.org/10.1002/ajmg.a.63095
Krarup, N T, Hvidbjerg, M, Zaremba, T, Sommerlund, M & Christensen, M K 2023, ' Autosomal dominant cutis laxa and critical stenosis of the left main coronary artery in a 21-year-old female with an intronic mutation in the elastin gene ', American Journal of Medical Genetics. Part A, vol. 191, no. 4, pp. 1059-1064 . https://doi.org/10.1002/ajmg.a.63095

Cutis laxa (CL) is a rare, inherited or acquired connective tissue disorder characterized by abnormal elastic fibers causing loose and redundant skin and a prematurely aged appearance. The syndrome has been associated with hypertension, but cases wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff2a6956da22fa4f2d26e3dd164829f2
https://pure.au.dk/portal/da/publications/autosomal-dominant-cutis-laxa-and-critical-stenosis-of-the-left-main-coronary-artery-in-a-21yearold-female-with-an-intronic-mutation-in-the-elastin-gene(f4aca951-9901-40bd-a559-aeae726952e5).html

Five-Year Clinical Outcome of the Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent Compared to the Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: From the SORT OUT VII Trial

Autor: Kirstine Nørregaard Hansen, Lisette Okkels Jensen, Michael Maeng, Martin Kirk Christensen, Manijeh Noori, Johnny Kahlert, Lars Jakobsen, Anders Junker, Phillip Freeman, Julia Ellert-Gregersen, Bent Raungaard, Christian Juhl Terkelsen, Karsten Tange Veien, Evald Høj Christiansen

Publikováno v: Hansen, K N, Jensen, L O, Maeng, M, Christensen, M K, Noori, M, Kahlert, J, Jakobsen, L, Junker, A, Freeman, P, Ellert-Gregersen, J, Raungaard, B, Terkelsen, C J, Veien, K T & Christiansen, E H 2023, ' Five-Year Clinical Outcome of the Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent Compared to the Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated with Percutaneous Coronary Intervention : From the SORT OUT VII Trial ', Circulation: Cardiovascular Interventions, vol. 16, no. 1, E012332 . https://doi.org/10.1161/CIRCINTERVENTIONS.122.012332
Hansen, K N, Jensen, L O, Maeng, M, Christensen, M K, Noori, M, Kahlert, J, Jakobsen, L, Junker, A, Freeman, P, Ellert-Gregersen, J, Raungaard, B, Terkelsen, C J, Veien, K T & Christiansen, E H 2023, ' Five-Year Clinical Outcome of the Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent Compared to the Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention : From the SORT OUT VII Trial ', Circulation. Cardiovascular Interventions, vol. 16, no. 1, e012332 . https://doi.org/10.1161/CIRCINTERVENTIONS.122.012332

Background: Biodegradable polymer drug-eluting stents were developed to improve safety and efficacy outcomes for patients undergoing percutaneous coronary intervention. However, few long-term follow-up efficacy studies are available. The study sought

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a439e95d999b87dee2a3c03f78f0666
https://doi.org/10.1161/circinterventions.122.012332

Randomized Clinical Comparison of the Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Combo Stent With the Sirolimus-Eluting Orsiro Stent in Patients Treated With Percutaneous Coronary Intervention:The SORT OUT X Trial

Autor: Troels Thim, Lars Jakobsen, Rebekka Vibjerg Jensen, Michael Maeng, Johnny Kahlert, Phillip Freeman, Henrik Steen Hansen, Anders Junker, Ashkan Eftekhari, Lisette Okkels Jensen, Anton Boel Villadsen, Ahmed Aziz, Hans Erik Bøtker, Evald Høj Christiansen, Leif Thuesen, Julia Ellert, Bent Raungaard, Jeppe Grøndahl Rasmussen, Svend Eggert Jensen, Nicolaj B. Støttrup, Steen Dalby Kristensen, Martin Kirk Christensen, Ole Ahlehoff, Christian Juhl Terkelsen, Jens Aarøe, Karsten Tange Veien

Publikováno v: Jakobsen, L, Christiansen, E H, Freeman, P, Kahlert, J, Veien, K, Maeng, M, Raungaard, B, Ellert, J, Villadsen, A B, Kristensen, S D, Ahlehoff, O, Christensen, M K, Terkelsen, C J, Erik Bøtker, H, Aaroe, J, Thim, T, Thuesen, L, Aziz, A, Eftekhari, A, Jensen, R V, Støttrup, N B, Rasmussen, J G, Junker, A, Jensen, S E, Hansen, H S & Jensen, L O 2021, ' Randomized Clinical Comparison of the Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Combo Stent With the Sirolimus-Eluting Orsiro Stent in Patients Treated With Percutaneous Coronary Intervention : The SORT OUT X Trial ', Circulation, vol. 143, no. 22, pp. 2155-2165 . https://doi.org/10.1161/CIRCULATIONAHA.120.052766
Jakobsen, L, Christiansen, E H, Freeman, P, Kahlert, J, Veien, K, Maeng, M, Raungaard, B, Ellert, J, Villadsen, A B, Kristensen, S D, Ahlehoff, O, Christensen, M K, Terkelsen, C J, Bøtker, H E, Aaroe, J, Thim, T, Thuesen, L, Aziz, A, Eftekhari, A, Jensen, R V, Støttrup, N B, Rasmussen, J G, Junker, A, Jensen, S E, Hansen, H S & Jensen, L O 2021, ' Randomized Clinical Comparison of the Dual Therapy CD34 Antibody-Covered Sirolimus-Eluting Combo Stent with the Sirolimus-Eluting Orsiro Stent in Patients Treated with Percutaneous Coronary Intervention : The SORT OUT X Trial ', Circulation, vol. 143, no. 22, pp. 2155-2165 . https://doi.org/10.1161/CIRCULATIONAHA.120.052766
Jakobsen, L, Christiansen, E H, Freeman, P, Kahlert, J, Veien, K, Maeng, M, Raungaard, B, Ellert, J, Villadsen, A B, Kristensen, S D, Ahlehoff, O, Christensen, M K, Terkelsen, C J, Bøtker, H E, Aaroe, J, Thim, T, Thuesen, L, Aziz, A, Eftekhari, A, Jensen, R V, Støttrup, N B, Rasmussen, J G, Junker, A, Jensen, S E, Hansen, H S & Jensen, L O 2021, ' Randomized clinical comparison of the dual-therapy CD34 antibody-covered sirolimus-eluting combo stent with the sirolimus-eluting Orsiro stent in patients treated with percutaneous coronary intervention : The SORT out X trial ', Circulation, vol. 143, no. 22, pp. 2155-2165 . https://doi.org/10.1161/CIRCULATIONAHA.120.052766

Background: Target lesion failure remains an issue with contemporary drug-eluting stents. Thus, the dual-therapy sirolimus-eluting and CD34+ antibody–coated Combo stent (DTS) was designed to further improve early healing. This study aimed to invest

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ac1d603e88f5ab95ac3f378d4cd72ac
https://vbn.aau.dk/da/publications/cf269f51-6a1f-4627-ba16-542a39439f54